801 related articles for article (PubMed ID: 11778074)
1. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
3. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
[TBL] [Abstract][Full Text] [Related]
4. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
6. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M
Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
[TBL] [Abstract][Full Text] [Related]
7. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
Kusadasi N; van Soest PL; Mayen AE; Koevoet JL; Ploemacher RE
Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
[TBL] [Abstract][Full Text] [Related]
8. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
9. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
[TBL] [Abstract][Full Text] [Related]
10. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
11. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M
Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480
[TBL] [Abstract][Full Text] [Related]
12. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
[TBL] [Abstract][Full Text] [Related]
13. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells.
Piacibello W; Gammaitoni L; Bruno S; Gunetti M; Fagioli F; Cavalloni G; Aglietta M
J Hematother Stem Cell Res; 2000 Dec; 9(6):945-56. PubMed ID: 11177609
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
16. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
[TBL] [Abstract][Full Text] [Related]
17. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
Levac K; Karanu F; Bhatia M
Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
[TBL] [Abstract][Full Text] [Related]
18. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
19. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice.
Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM
Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381
[TBL] [Abstract][Full Text] [Related]
20. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
